L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.
“Since then, pharmacists have provided support for more than 5000 women, improving access to treatment and freeing up thousands of GP appointments or presentations to the Emergency Department,” ...